Richard H. Bell - Researcher Profile

Publications

2 shown

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

Martine Piccart , Marion Procter , Brian Leyland‐Jones +29 more

One year of treatment with trastuzumab after adjuvant chemotherapy significantly improves disease-free survival among women with HER2-positive breast cancer. (ClinicalTrials.gov...

2005 New England Journal of Medicine 5034 citations

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

Ian Smith , Marion Procter , Richard D. Gelber +21 more

2007 The Lancet 1503 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 6,537
Institution: Geelong Hospital

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-0624-3348

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.